InflaRx (IFRX) Return on Sales (2023 - 2025)

InflaRx has disclosed Return on Sales across 3 years of filings, most recently posting 250677.59% for Q4 2025.

• Return on Sales for Q4 2025 came in at 250677.59%, down 24965610.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 188869.55% (up 18886928.0% YoY), and the FY2025 annual result was 15.56%, down 1278.0% from the prior year.
• Return on Sales came in at 250677.59% for Q4 2025 at InflaRx, down from 0.8% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.8% in Q3 2025 to a low of 250677.59% in Q4 2025.
• The 3-year median for Return on Sales is 3.47% (2025), against an average of 27976.72%.
• Peak annual rise in Return on Sales reached 1843 bps in 2025, while the deepest fall reached 24965610 bps in 2025.
• InflaRx's Return on Sales stood at 58.43% in 2023, then slumped by 1648 bps to 1021.48% in 2024, then plunged by 24441 bps to 250677.59% in 2025.
• The last three Return on Sales figures came in at 250677.59% (Q4 2025), 0.8% (Q3 2025), and 3.02% (Q2 2025), per Business Quant data.